Diabetic polyneuropathy: from problem to solution
Diabetes mellitus (DM) is a challenging non-infectious epidemic of the modern world. A steady increase in the number of patients and late diagnosis of the disease predestine the high relevance of this problem. Diabetic polyneuropathy (DPN) is one of the most dangerous complications of diabetes. Choosing the right-pharmacotherapy is important to correctly slow down the progression of DPN [1].